The amazing innate immune response to influenza A virus infection

Innate Immunity

Volumn 21, Issue 1, 2015, Pages 73-98

  Tripathi, Shweta ^a   White, Mitchell R ^a   Hartshorn, Kevan L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Collectin; interferon; LL 37; neutrophil; p53

Indexed keywords

ALPHA DEFENSIN; ANTIVIRUS AGENT; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLLECTIN; GALAPTIN; GALECTIN 1; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN M; INFLAMMASOME; INTERLEUKIN 17; MICRORNA; MYXOVIRUS RESISTANCE PROTEIN; PROTEIN P53; SIALIC ACID;

APOPTOSIS; AUTOPHAGY; BACTERIAL SUPERINFECTION; CELL DEATH; CELL STRESS; ENDOTHELIUM CELL; EPITHELIUM CELL; HOST RESISTANCE; HUMAN; HYDROPHOBICITY; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; INFLAMMATION; INFLUENZA A; INFLUENZA VIRUS A; INNATE IMMUNITY; LUNG INJURY; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; REVIEW; SWINE; T LYMPHOCYTE; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS;

INFLUENZA A VIRUS;

HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS; INFLUENZA, HUMAN;

EID: 84914145530     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425913508992     Document Type: Review

References (319)

1. White MR, Doss M, Boland P, et al. Innate immunity to influenza virus: implications for future therapy. Expert Rev Clin Immunol. 2008 ; 4: 497-514
2. Kawaoka Y, Neumann G. Influenza viruses: an introduction. Methods Mol Biol. 2013 ; 865: 1-9
3. Hufford MM, Richardson G, Zhou H, et al. Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells. PLoS One. 2012 ; 7: e46581 - e46581
4. Hartshorn KL. New look at an old problem. Bacterial superinfection after influenza. Am J Pathol. 2010 ; 176: 536-539
5. Riese RJ, Finn PW, Shapiro SD. Influenza and asthma: adding to the respiratory burden. Nature Immunol. 2004 ; 5: 243-244
6. Braciale TJ, Sun J, Kim TS. Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol. 2012 ; 12: 295-305
7. Mansour DE, El-Shazly AA, Elawamry AI, et al. Comparison of ocular findings in patients with H1N1 influenza infection versus patients receiving influenza vaccine during a pandemic. Ophthalmic Res. 2012 ; 48: 134-138
8. Belser JA, Gustin KM, Maines TR, et al. Influenza virus respiratory infection and transmission following ocular inoculation in ferrets. PLoS Pathog. 2012 ; 8: e1002569 - e1002569
9. Belser JA, Zeng H, Katz JM, et al. Ocular tropism of influenza A viruses: identification of H7 subtype-specific host responses in human respiratory and ocular cells. J Virol. 2011 ; 85: 10117-10125
10. McDermott AM. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res. 2009 ; 41: 60-75
11. McCormick CC, Hobden JA, Balzli CL, et al. Surfactant protein D in Pseudomonas aeruginosa keratitis. Ocul Immunol Inflamm. 2007 ; 15: 371-379
12. Ni M, Evans DJ, Hawgood S, et al. Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun. 2005 ; 73: 2147-2156
13. Cole AM, Dewan P, Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun. 1999 ; 67: 3267-3275
14. White MR, Helmerhorst EJ, Ligtenberg A, et al. Multiple components contribute to ability of saliva to inhibit influenza viruses. Oral Microbiol Immunol. 2009 ; 24: 18-24
15. Cohen A, Biddle F, Newland SE. Analysis of horse serum inhibitors of A2 influenza virus haemagglutination. Br J Exp Pathol. 1965 ; 46: 497-513
16. Verma A, White M, Vathipadiekal V, et al. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses. J Immunol. 2012 ; 189: 2478-2487
17. Hartshorn KL, Ligtenberg A, White MR, et al. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem J. 2006 ; 393: 545-553
18. White MR, Crouch E, van Eijk M, et al. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. Am J Physiol Lung Cell Mol Physiol. 2005 ; 288: L831 - L840
19. Hartshorn KL. Role of surfactant protein A and D (SP-A and SP-D) in human antiviral host defense. Front Biosci (Schol Ed). 2010 ; 2: 527-546
20. Li G, Siddiqui J, Hendry M, et al. Surfactant protein-A - deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. Am J Respir Cell Mol Biol. 2002 ; 26: 277-282
21. LeVine AM, Hartshorn K, Elliott J, et al. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol. 2002 ; 282: L563 - L572
22. Hartshorn KL, White MR, Mogues T, et al. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol. 2003 ; 285: L1066 - L1076
23. Reading PC, Bozza S, Gilbertson B, et al. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol. 2008 ; 180: 3391-3398
24. LeVine AM, Whitsett JA, Hartshorn KL, et al. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol. 2001 ; 167: 5868-5873
25. Hartshorn KL, Crouch EC, White MR, et al. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest. 1994 ; 94: 311-319
26. Qi L, Kash JC, Dugan VG, et al. The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding. Virology. 2011 ; 412: 426-434
27. Hartshorn KL, Webby R, White MR, et al. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir Res. 2008 ; 9: 65-65
28. Tate MD, Brooks AG, Reading PC. Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice. J Immunol. 2012 ; 187: 1884-1894
29. Job ER, Deng YM, Tate MD, et al. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J Immunol. 2010 ; 185: 4284-4291
30. Tumpey TM, Garcia-Sastre A, Taubenberger JK, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol. 2005 ; 79: 14933-14944
31. Kongchanagul A, Suptawiwat O, Boonarkart C, et al. Decreased expression of surfactant protein D mRNA in human lungs in fatal cases of H5N1 avian influenza. J Med Virol. 2011 ; 83: 1410-1417
32. Sims MW, Tal-Singer RM, Kierstein S, et al. Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study. Respir Res. 2008 ; 9: 13-13
33. Honda Y, Takahashi H, Kuroki Y, et al. Decreased contents of surfactant proteins A and D in BAL fluids of Healthy smokers. Chest. 1996 ; 109: 1006-1009
34. Reading P, Allison J, Crouch E, et al. Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose. J Virol. 1998 ; 72: 6884-6887
35. Noah TL, Murphy PC, Alink JJ, et al. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med. 2003 ; 168: 685-691
36. Postle A, Mander A, Reid K, et al. Deficient hydrophilic surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Resp Cell Mol Biol. 1999 ; 20: 90-98
37. Hartshorn KL, White MR, Tecle T, et al. Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D. Respir Res. 2007 ; 8: 9-9
38. Leth-Larsen R, Garred P, Jensenius H, et al. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol. 2005 ; 174: 1532-1538
39. Kingma PS, Zhang L, Ikegami M, et al. Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D. J Biol Chem. 2006 ; 281: 24496-24505
40. Hawgood S, Brown C, Edmondson J, et al. Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol. 2004 ; 78: 8565-8572
41. Pastva AM, Wright JR, Williams KL. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc. 2007 ; 4: 252-257
42. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005 ; 5: 58-68
43. Gardai S, Xiao Y, Dickinson M, et al. By binding SIRP or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell. 2003 ; 115: 13-23
44. Guo CJ, Atochina-Vasserman EN, Abramova E, et al. S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol. 2008 ; 6: e266 - e266
45. Chang WC, Hartshorn KL, White MR, et al. Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol. 2011 ; 81: 388-395
46. Reading PC, Morey LS, Crouch EC, et al. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol. 1997 ; 71: 8204-8212
47. Ling MT, Tu W, Han Y, et al. Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection. J Infect Dis. 2012 ; 205: 44-53
48. Chang WC, White MR, Moyo P, et al. Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection. BMC Immunol. 2010 ; 11: 64-64
49. Hartshorn KL, White MR, Shepherd V, et al. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol. 1997 ; 273: L1156 - L1166
50. van Eijk M, White MR, Crouch EC, et al. Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain. J Immunol. 2003 ; 171: 1431-1440
51. van Eijk M, White MR, Batenburg JJ, et al. Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am J Respir Cell Mol Biol. 2004 ; 30: 871-879
52. van Eijk M, van de Lest CH, Batenburg JJ, et al. Porcine surfactant protein D is N-glycosylated in its carbohydrate recognition domain and is assembled into differently charged oligomers. Am J Respir Cell Mol Biol. 2002 ; 26: 739-747
53. Thiel S, Gadjeva M. Humoral pattern recognition molecules: mannan-binding lectin and ficolins. Adv Exp Med Biol. 2009 ; 653: 58-73
54. Pan Q, Chen H, Wang F, et al. L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo. J Innate Immun. 2012 ; 4: 312-324
55. Takahashi K, Ip WE, Michelow IC, et al. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol. 2006 ; 18: 16-23
56. Munthe-Fog L, Hummelshoj T, Honore C, et al. Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med. 2009 ; 360: 2637-2644
57. Yang ML, Chen YH, Wang SW, et al. Galectin-1 binds to influenza virus and ameliorates influenza virus pathogenesis. J Virol. 2011 ; 85: 10010-10020
58. Glasser SW, Witt TL, Senft AP, et al. Surfactant protein C deficient mice are susceptible to respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol. 2009 ; 297: L64 - L72
59. Numata M, Kandasamy P, Nagashima Y, et al. Phosphatidylglycerol suppresses influenza A virus infection. Am J Respir Cell Mol Biol. 2012 ; 46: 479-487
60. Tecle T, Tripathi S, Hartshorn KL. Review: Defensins and cathelicidins in lung immunity. Innate Immun. 2010 ; 16: 151-159
61. Doss M, White MR, Tecle T, et al. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol. 2010 ; 87: 79-92
62. Doss M, White MR, Tecle T, et al. Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J Immunol. 2009 ; 182: 7878-7887
63. Salvatore M, Garcia-Sastre A, Ruchala P, et al. alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). J Infect Dis. 2007 ; 196: 835-843
64. Hartshorn KL, White MR, Tecle T, et al. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. J Immunol. 2006 ; 176: 6962-6972
65. Doss M, Ruchala P, Tecle T, et al. Hapivirins and diprovirins: novel theta-defensin analogs with potent activity against influenza A virus. J Immunol. 2012 ; 188: 2759-2768
66. Tecle T, White MR, Gantz D, et al. Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J Immunol. 2007 ; 178: 8046-8052
67. Jiang Y, Wang Y, Kuang Y, et al. Expression of mouse beta-defensin-3 in MDCK cells and its anti-influenza-virus activity. Arch Virol. 2009 ; 154: 639-647
68. Ryan LK, Dai J, Yin Z, et al. Modulation of human beta-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity. J Leukoc Biol. 2011 ; 90: 343-356
69. Liang QL, Zhou K, He HX. Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro. Biotechnol Lett. 2009 ; 32: 387-392
70. Gaudreault E, Gosselin J. Leukotriene B4 induces release of antimicrobial peptides in lungs of virally infected mice. J Immunol. 2008 ; 180: 6211-6221
71. Barlow PG, Svoboda P, Mackellar A, et al. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One. 2011 ; 6: e25333 - e25333
72. Tripathi S, Tecle T, Verma A, et al. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. J Gen Virol. 2013 ; 94: 40-49
73. Zhou J, To KK, Dong H, et al. A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection. J Infect Dis. 2012 ; 206: 495-503
74. Zuniga J, Buendia-Roldan I, Zhao Y, et al. Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J. 2012 ; 39: 604-610
75. O'Brien KB, Morrison TE, Dundore DY, et al. A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection. PLoS One. 2011 ; 6: e17377 - e17377
76. Sun S, Zhao G, Liu C, et al. Inhibition of complement activation alleviates acute lung injury induced by HPAI H5N1 virus infection. Am J Respir Cell Mol Biol. 2013 ; 49: 221-230
77. Jayasekera JP, Moseman EA, Carroll MC. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol. 2007 ; 81: 3487-3494
78. Stros M, Cherny D, Jovin TM. HMG1 protein stimulates DNA end joining by promoting association of DNA molecules via their ends. Eur J Biochem. 2000 ; 267: 4088-4097
79. Hughes EN, Engelsberg BN, Billings PC. Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2. J Biol Chem. 1992 ; 267: 13520-13527
80. Yanai H, Ban T, Taniguchi T. High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol. 2012 ; 33: 633-640
81. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011 ; 29: 139-162
82. Ito Y, Torii Y, Ohta R, et al. Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children. Cytokine. 2011 ; 56: 180-187
83. Kosai K, Seki M, Yanagihara K, et al. Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus. Scand J Infect Dis. 2008 ; 40: 338-342
84. Alleva LM, Budd AC, Clark IA. Systemic release of high mobility group box 1 protein during severe murine influenza. J Immunol. 2008 ; 181: 1454-1459
85. Moisy D, Avilov SV, Jacob Y, et al. HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication. J Virol. 2012 ; 86: 9122-9133
86. Shornick LP, Wells AG, Zhang Y, et al. Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J Immunol. 2008 ; 180: 3319-3328
87. Unkel B, Hoegner K, Clausen BE, et al. Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. J Clin Invest. 2012 ; 122: 3652-3664
88. Kosmider B, Messier EM, Janssen WJ, et al. Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus. Respir Res. 2012 ; 13: 43-43
89. Wang J, Oberley-Deegan R, Wang S, et al. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda1) in response to influenza A infection. J Immunol. 2009 ; 182: 1296-1304
90. Wang J, Nikrad MP, Phang T, et al. Innate immune response to influenza A virus in differentiated human alveolar type II cells. Am J Respir Cell Mol Biol. 2011 ; 45: 582-591
91. Mordstein M, Kochs G, Dumoutier L, et al. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 2008 ; 4: e1000151 - e1000151
92. Jewell NA, Cline T, Mertz SE, et al. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol. 2010 ; 84: 11515-11522
93. Kroeker AL, Ezzati P, Halayko AJ, et al. Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study. J Proteome Res. 2012 ; 11: 4132-4146
94. Hsu AC, Parsons K, Barr I, et al. Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection. PLoS One. 2012 ; 7: e32947 - e32947
95. Pichlmair A, Schulz O, Tan CP, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5-phosphates. Science. 2006 ; 314: 997-1001
96. Le Goffic R, Pothlichet J, Vitour D, et al. Cutting edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol. 2007 ; 178: 3368-3372
97. Le Goffic R, Balloy V, Lagranderie M, et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2006 ; 2: e53 - e53
98. Guillot L, Le Goffic R, Bloch S, et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem. 2005 ; 280: 5571-5580
99. Diebold SS, Kaisho T, Hemmi H, et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004 ; 303: 1529-1531
100. Wang JP, Liu P, Latz E, et al. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol. 2006 ; 177: 7114-7121
101. Takeuchi O, Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol. 2008 ; 20: 17-22
102. Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008 ; 133: 235-249
103. Loof TG, Morgelin M, Johansson L, et al. Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood. 2011 ; 118: 2589-2598
104. Nhu QM, Shirey K, Teijaro JR, et al. Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol. 2010 ; 3: 29-39
105. Lan RS, Stewart GA, Goldie RG, et al. Altered expression and in vivo lung function of protease-activated receptors during influenza A virus infection in mice. Am J Physiol Lung Cell Mol Physiol. 2004 ; 286: L388 - L398
106. Khoufache K, Berri F, Nacken W, et al. PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest. 2013 ; 123: 206-214
107. Antoniak S, Owens AP, Baunacke M, et al. PAR-1 contributes to the innate immune response during viral infection. J Clin Invest. 2013 ; 123: 1310-1322
108. Khoufache K, LeBouder F, Morello E, et al. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol. 2009 ; 182: 7795-7802
109. Durbin JE, Fernandez-Sesma A, Lee CK, et al. Type I IFN modulates innate and specific antiviral immunity. J Immunol. 2000 ; 164: 4220-4228
110. Garcia-Sastre A. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology. 2001 ; 279: 375-384
111. Brass AL, Huang IC, Benita Y, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell. 2009 ; 139: 1243-1254
112. Everitt AR, Clare S, Pertel T, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature. 2012 ; 484: 519-523
113. Mangeat B, Cavagliotti L, Lehmann M, et al. Influenza virus partially counteracts restriction imposed by tetherin/BST-2. J Biol Chem. 2012 ; 287: 22015-22029
114. Wang X, Hinson ER, Cresswell P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe. 2007 ; 2: 96-105
115. Tan KS, Olfat F, Phoon MC, et al. In vivo and in vitro studies on the antiviral activities of viperin against influenza H1N1 virus infection. J Gen Virol. 2012 ; 93: 1269-1277
116. Cilloniz C, Pantin-Jackwood MJ, Ni C, et al. Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival. J Virol. 2011 ; 86: 2437-2446
117. Dittmann J, Stertz S, Grimm D, et al. Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J Virol. 2008 ; 82: 3624-3631
118. Zimmermann P, Manz B, Haller O, et al. The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J Virol. 2011 ; 85: 8133-8140
119. Wisskirchen C, Ludersdorfer TH, Muller DA, et al. Interferon-induced antiviral protein MxA interacts with the cellular RNA helicases UAP56 and URH49. J Biol Chem. 2011 ; 286: 34743-34751
120. Turpin E, Luke K, Jones J, et al. Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol. 2005 ; 79: 8802-8811
121. Wang X, Deng X, Yan W, et al. Stabilization of p53 in influenza A virus-infected cells is associated with compromised MDM2-mediated ubiquitination of p53. J Biol Chem. 2012 ; 287: 18366-18375
122. Terrier O, Marcel V, Cartet G, et al. Influenza A viruses control expression of proviral human p53 isoforms p53beta and Delta133p53alpha. J Virol. 2012 ; 86: 8452-8460
123. Munoz-Fontela C, Pazos M, Delgado I, et al. p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. J Immunol. 2011 ; 187: 6428-6436
124. Wang X, Shen Y, Qiu Y, et al. The non-structural (NS1) protein of influenza A virus associates with p53 and inhibits p53-mediated transcriptional activity and apoptosis. Biochem Biophys Res Commun. 2010 ; 395: 141-145
125. Lamkanfi M, Dixit VM. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe. 2010 ; 8: 44-54
126. Yatim N, Albert ML. Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity. Immunity. 2011 ; 35: 478-490
127. Zhirnov OP, Klenk HD. Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis. 2007 ; 12: 1419-1432
128. Hrincius ER, Dierkes R, Anhlan D, et al. Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production. Cell Microbiol. 2011 ; 13: 1907-1919
129. Ruckle A, Haasbach E, Julkunen I, et al. The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-kappaB pathway and p52/RelB-dependent gene expression in lung epithelial cells. J Virol. 2012 ; 86: 10211-10217
130. Ehrhardt C, Wolff T, Pleschka S, et al. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol. 2007 ; 81: 3058-3067
131. Hale BG, Jackson D, Chen YH, et al. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A. 2006 ; 103: 14194-14199
132. Herold S, Ludwig S, Pleschka S, et al. Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury. J Leukoc Biol. 2012 ; 92: 75-82
133. Gaur P, Ranjan P, Sharma S, et al. Influenza A virus neuraminidase protein enhances cell survival through interaction with carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) protein. J Biol Chem. 2012 ; 287: 15109-15117
134. Wurzer WJ, Planz O, Ehrhardt C, et al. Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J. 2003 ; 22: 2717-2728
135. Mazur I, Wurzer WJ, Ehrhardt C, et al. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol. 2007 ; 9: 1683-1694
136. Wurzer WJ, Ehrhardt C, Pleschka S, et al. NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem. 2004 ; 279: 30931-30937
137. Zamarin D, Garcia-Sastre A, Xiao X, et al. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 2005 ; 1: e4 - e4
138. Akaike T, Noguchi Y, Ijiri S, et al. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci U S A. 1996 ; 93: 2448-2453
139. Oda T, Akaike T, Hamamoto T, et al. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science. 1989 ; 244: 974-976
140. Choi A, Knobil K, Otterbein S, et al. Oxidant stress responses in influenza virus pneumona: gene expression and transcription factor activation. Am J Physiol. 1996 ; 271: L383-391
141. Yageta Y, Ishii Y, Morishima Y, et al. Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice. J Virol. 2011 ; 85: 4679-4690
142. Kesic MJ, Simmons SO, Bauer R, et al. Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free Radic Biol Med. 2011 ; 51: 444-453
143. Harvey CJ, Thimmulappa RK, Sethi S, et al. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med. 2011 ; 3: 78ra32-78ra32
144. Lamkanfi M, Dixit VM. Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol. 2011 ; 187: 597-602
145. Dumit VI, Dengjel J. Autophagosomal protein dynamics and influenza virus infection. Front Immunol. 2012 ; 3: 43-43
146. Kuballa P, Nolte WM, Castoreno AB, et al. Autophagy and the immune system. Annu Rev Immunol. 2012 ; 30: 611-646
147. Gannage M, Ramer PC, Munz C. Targeting Beclin 1 for viral subversion of macroautophagy. Autophagy. 2010 ; 6: 166-167
148. Gannage M, Dormann D, Albrecht R, et al. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe. 2009 ; 6: 367-380
149. Law AH, Lee DC, Yuen KY, et al. Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction. Cell Mol Immunol. 2010 ; 7: 263-270
150. Comber JD, Robinson TM, Siciliano NA, et al. Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation. J Virol. 2011 ; 85: 6453-6463
151. Sun Y, Li C, Shu Y, et al. Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection. Sci Signal. 2012 ; 5: ra16 - ra16
152. Ma J, Sun Q, Mi R, et al. Avian influenza A virus H5N1 causes autophagy-mediated cell death through suppression of mTOR signaling. J Genet Genomics. 2011 ; 38: 533-537
153. Widjaja I, de Vries E, Tscherne DM, et al. Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step. J Virol. 2010 ; 84: 9625-9631
154. Buchan JR, Parker R. Eukaryotic stress granules: the ins and outs of translation. Mol Cell. 2009 ; 36: 932-941
155. Okonski KM, Samuel CE. Stress granule formation induced by measles virus is protein kinase PKR-dependent and impaired by RNA adenosine deaminase ADAR1. J Virol. 2013 ; 87: 756-766
156. Simpson-Holley M, Kedersha N, Dower K, et al. Formation of antiviral cytoplasmic granules during orthopoxvirus infection. J Virol. 2011 ; 85: 1581-1593
157. Lindquist ME, Lifland AW, Utley TJ, et al. Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J Virol. 2010 ; 84: 12274-12284
158. Beckham CJ, Parker R. P bodies, stress granules, and viral life cycles. Cell Host Microbe. 2008 ; 3: 206-212
159. Ariumi Y, Kuroki M, Kushima Y, et al. Hepatitis C virus hijacks P-body and stress granule components around lipid droplets. J Virol. 2011 ; 85: 6882-6892
160. Garaigorta U, Heim MH, Boyd B, et al. Hepatitis C virus (HCV) induces formation of stress granules whose proteins regulate HCV RNA replication and virus assembly and egress. J Virol. 2012 ; 86: 11043-11056
161. Onomoto K, Jogi M, Yoo JS, et al. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One. 2012 ; 7: e43031 - e43031
162. Mok BW, Song W, Wang P, et al. The NS1 protein of influenza A virus interacts with cellular processing bodies and stress granules through RNA-associated protein 55 (RAP55) during virus infection. J Virol. 2012 ; 86: 12695-12707
163. Song L, Liu H, Gao S, et al. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol. 2010 ; 84: 8849-8860
164. Li W, Li H, Lu R, et al. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. PNAS. 2004 ; 101: 1350-1355
165. Fang J, Hao Q, Liu L, et al. Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection. J Virol. 2012 ; 86: 1010-1020
166. Buggele WA, Johnson KE, Horvath CM. Influenza A virus infection of human respiratory cells induces primary microRNA expression. J Biol Chem. 2012 ; 287: 31027-31040
167. Teijaro JR, Walsh KB, Cahalan S, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell. 2011 ; 146: 980-991
168. Iwasaki A, Medzhitov R. A new shield for a cytokine storm. Cell. 2011 ; 146: 861-862
169. Teske S, Bohn AA, Regal JF, et al. Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus. Am J Physiol Lung Cell Mol Physiol. 2005 ; 289: L111 - L124
170. Wheeler JL, Martin KC, Lawrence BP. Novel cellular targets of AhR underlie alterations in neutrophilic inflammation and inducible nitric oxide synthase expression during influenza virus infection. J Immunol. 2013 ; 190: 659-668
171. Kim HM, Lee YW, Lee KJ, et al. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol. 2008 ; 82: 4265-4274
172. Tate MD, Pickett DL, van Rooijen N, et al. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol. 2010 ; 84: 7569-7580
173. Sever-Chroneos Z, Murthy A, Davis J, et al. GM-CSF modulates pulmonary resistance to influenza A infection. Antiviral Res. 2011 ; 92: 319-328
174. Huang FF, Barnes PF, Feng Y, et al. GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med. 2011 ; 184: 259-268
175. Pang IK, Iwasaki A. Inflammasomes as mediators of immunity against influenza virus. Trends Immunol. 2011 ; 32: 34-41
176. Thomas PG, Dash P, Aldridge JR, et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity. 2009 ; 30: 566-575
177. Allen IC, Scull MA, Moore CB, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009 ; 30: 556-565
178. Ichinohe T, Lee HK, Ogura Y, et al. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med. 2009 ; 206: 79-87
179. Schmitz N, Kurrer M, Bachmann MF, et al. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol. 2005 ; 79: 6441-6448
180. Ichinohe T, Pang IK, Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol. 2010 ; 11: 404-410
181. Lupfer C, Thomas PG, Anand PK, et al. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection. Nat Immunol. 2013 ; 14: 480-488
182. Stout-Delgado HW, Vaughan SE, Shirali AC, et al. Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin. J Immunol. 2012 ; 188: 2815-2824
183. Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A. 2011 ; 108: 5354-5359
184. Abt MC, Osborne LC, Monticelli LA, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity. 2012 ; 37: 158-170
185. Hashimoto Y, Moki T, Takizawa T, et al. Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol. 2007 ; 178: 2448-2457
186. Watanabe Y, Hashimoto Y, Shiratsuchi A, et al. Augmentation of fatality of influenza in mice by inhibition of phagocytosis. Biochem Biophys Res Commun. 2005 ; 337: 881-886
187. Tacken PJ, Hartshorn KL, White MR, et al. Effective targeting of pathogens to neutrophils via chimeric surfactant protein D/anti-CD89 protein. J Immunol. 2004 ; 172: 4934-4940
188. Hartshorn KL, Holmskov U, Hansen S, et al. Distinctive anti-influenza properties of recombinant collectin 43. Biochem J. 2002 ; 366: 87-96
189. White MR, Crouch E, Chang D, et al. Increased antiviral and opsonic activity of a highly multimerized collectin chimera. Biochem Biophys Res Commun. 2001 ; 286: 132-206
190. Hartshorn KL, Liou LS, White MR, et al. Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J Immunol. 1995 ; 154: 3952-3960
191. Hartshorn KL, Sastry K, White MR, et al. Human mannose-binding protein functions as an opsonin for influenza A viruses. J Clin Invest. 1993 ; 91: 1414-1420
192. Hartshorn KL, Sastry K, Brown D, et al. Conglutinin acts as an opsonin for influenza A viruses. J Immunol. 1993 ; 151: 6265-6273
193. Hartshorn KL, White MR, Tecle T, et al. Viral aggregating and opsonizing activity in collectin trimers. Am J Physiol Lung Cell Mol Physiol. 2010 ; 298: L79 - L88
194. Londrigan SL, Tate MD, Brooks AG, et al. Cell-surface receptors on macrophages and dendritic cells for attachment and entry of influenza virus. J Leukoc Biol. 2012 ; 92: 97-106
195. Londrigan SL, Turville SG, Tate MD, et al. N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN. J Virol. 2011 ; 85: 2990-3000
196. Tate MD, Brooks AG, Reading PC. Inhibition of lectin-mediated innate host defences in vivo modulates disease severity during influenza virus infection. Immunol Cell Biol. 2011 ; 89: 482-491
197. Ghosh S, Gregory D, Smith A, et al. MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome. Am J Respir Cell Mol Biol. 2011 ; 45: 1036-1044
198. Wang J, Nikrad MP, Travanty EA, et al. Innate immune response of human alveolar macrophages during influenza A infection. PLoS One. 2012 ; 7: e29879 - e29879
199. Cline TD, Karlsson EA, Seufzer BJ, et al. The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages. J Virol. 2012 ; 87: 1411-1419
200. Yu WC, Chan RW, Wang J, et al. Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J Virol. 2011 ; 85: 6844-6855
201. Lee SM, Cheung CY, Nicholls JM, et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis. 2008 ; 198: 525-535
202. Cheung C, Poon L, Lau A, et al. Induction of pro-inflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet. 2002 ; 360: 1831-1837
203. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A. 2007 ; 104: 12479-12481
204. Jakab GJ, Green GM. Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virus-infected murine lungs. J Clin Invest. 1976 ; 57: 1533-1539
205. Hartshorn KL, Reid KB, White MR, et al. Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood. 1996 ; 87: 3450-3461
206. Daigneault DE, Hartshorn KL, Liou LS, et al. Influenza A virus binding to human neutrophils and cross-linking requirements for activation. Blood. 1992 ; 80: 3227-3234
207. Hartshorn KL, Collamer M, Auerbach M, et al. Effects of influenza A virus on human neutrophil calcium metabolism. J Immunol. 1988 ; 141: 1295-1301
208. Hartshorn KL, Tauber AI. The influenza virus-infected phagocyte. A model of deactivation. Hematol Oncol Clin North Am. 1988 ; 2: 301-315
209. Engelich G, White M, Hartshorn KL. Neutrophil survival is markedly reduced by incubation with influenza virus and Streptococcus pneumoniae: role of respiratory burst. J Leukoc Biol. 2001 ; 69: 50-56
210. Colamussi M, White M, Crouch E, et al. Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood. 1999 ; 93: 2395-2403
211. McNamee LA, Harmsen AG. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun. 2006 ; 74: 6707-6721
212. Cassidy LF, Lyles DS, Abramson JS. Depression of polymorphonuclear leukocyte functions by purified influenza virus hemagglutinin and sialic acid-binding lectins. J Immunol. 1989 ; 142: 4401-4406
213. Abramson JS, Giebink GS, Quie PG. Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect Immun. 1982 ; 36: 289-296
214. Didierlaurent A, Goulding J, Patel S, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med. 2008 ; 205: 323-329
215. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med. 2008 ; 14: 558-564
216. Ghoneim HE, Thomas PG, McCullers JA. Depletion of Alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol. 2013 ; 191: 1250-1259
217. Lin KL, Suzuki Y, Nakano H, et al. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol. 2008 ; 180: 2562-2572
218. Cao W, Taylor AK, Biber RE, et al. Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection. J Immunol. 2012 ; 189: 2257-2265
219. Gong D, Farley K, White M, et al. Critical role of serpinB1 in regulating inflammatory responses in pulmonary influenza infection. J Infect Dis. 2011 ; 204: 592-600
220. Grayson MH, Holtzman MJ. Emerging role of dendritic cells in respiratory viral infection. J Mol Med. 2007 ; 85: 1057-1068
221. Grayson MH, Ramos MS, Rohlfing MM, et al. Controls for lung dendritic cell maturation and migration during respiratory viral infection. J Immunol. 2007 ; 179: 1438-1448
222. Jewell NA, Vaghefi N, Mertz SE, et al. Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol. 2007 ; 81: 9790-9800
223. Piqueras B, Connolly J, Freitas H, et al. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood. 2006 ; 107: 2613-2618
224. Fernandez-Sesma A, Marukian S, Ebersole BJ, et al. Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol. 2006 ; 80: 6295-6304
225. Hao X, Kim TS, Braciale TJ. Differential response of respiratory dendritic cell subsets to influenza virus infection. J Virol. 2008 ; 82: 4908-4919
226. Thitithanyanont A, Engering A, Ekchariyawat P, et al. High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J Immunol. 2007 ; 179: 5220-5227
227. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008 ; 358: 261-273
228. Ganguly D, Chamilos G, Lande R, et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 2009 ; 206: 1983-1994
229. Presicce P, Giannelli S, Taddeo A, et al. Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91. J Leukoc Biol. 2009 ; 86: 941-948
230. Wang JY, Reid KB. The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation. Immunobiology. 2007 ; 212: 417-425
231. Davidson DJ, Currie AJ, Reid GS, et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol. 2004 ; 172: 1146-1156
232. Snelgrove RJ, Edwards L, Rae AJ, et al. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol. 2006 ; 36: 1364-1373
233. White MR, Tecle T, Crouch EC, et al. Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid. Am J Physiol Lung Cell Mol Physiol. 2007 ; 293: L1293 - L1299
234. Hirche TO, Crouch EC, Espinola M, et al. Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved sub-region of the carbohydrate recognition domain. J Biol Chem. 2004 ; 279: 27688-27698
235. Narasaraju T, Yang E, Samy RP, et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol. 2011 ; 179: 199-210
236. Tate MD, Ioannidis LJ, Croker B, et al. The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One. 2011 ; 6: e17618 - e17618
237. Tate MD, Deng YM, Jones JE, et al. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol. 2009 ; 183: 7441-7450
238. Fujisawa H, Tsuru S, Taniguchi M, et al. Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes ond of alveolar mactrophages to protection during the early phase of intranasal infection. J Gen Virol. 1987 ; 68: 425-432
239. Hemmers S, Teijaro JR, Arandjelovic S, et al. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS One. 2011 ; 6: e22043 - e22043
240. Tate MD, Brooks AG, Reading PC, et al. Neutrophils sustain effective CD8(+) T-cell responses in the respiratory tract following influenza infection. Immunol Cell Biol. 2012 ; 90: 197-205
241. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol. 2013 ; 31: 163-194
242. Gazit R, Gruda R, Elboim M, et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol. 2006 ; 7: 517-523
243. Kumar P, Thakar MS, Ouyang W, et al. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol. 2012 ; 6: 69-82
244. Paget C, Ivanov S, Fontaine J, et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J Biol Chem. 2012 ; 287: 8816-8829
245. Verbist KC, Rose DL, Cole CJ, et al. IL-15 participates in the respiratory innate immune response to influenza virus infection. PLoS One. 2012 ; 7: e37539 - e37539
246. Abdul-Careem MF, Mian MF, Yue G, et al. Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis. 2012 ; 206: 167-177
247. Wortham BW, Eppert BL, Motz GT, et al. NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease. J Immunol. 2012 ; 188: 4468-4475
248. Kok WL, Denney L, Benam K, et al. Pivotal advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection. J Leukoc Biol. 2012 ; 91: 357-368
249. Paget C, Ivanov S, Fontaine J, et al. Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia. J Immunol. 2011 ; 186: 5590-5602
250. Guo H, Kumar P, Moran TM, et al. The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol. 2009 ; 87: 579-589
251. Mao H, Tu W, Qin G, et al. Influenza virus directly infects human natural killer cells and induces cell apoptosis. J Virol. 2009 ; 83: 9215-9222
252. Small CL, Shaler CR, McCormick S, et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol. 2010 ; 184: 2048-2056
253. Arnon TI, Lev M, Katz G, et al. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol. 2001 ; 31: 2680-2689
254. Mendelson M, Tekoah Y, Zilka A, et al. NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J Virol. 2010 ; 84: 3789-3797
255. Ge MQ, Ho AW, Tang Y, et al. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-gamma and perforin-dependent mechanisms. J Immunol. 2012 ; 189: 2099-2109
256. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010 ; 464: 1367-1370
257. Le Goffic R, Arshad MI, Rauch M, et al. Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol. 2011 ; 45: 1125-1132
258. Chang YJ, Kim HY, Albacker LA, et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol. 2011 ; 12: 631-638
259. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009 ; 361: 1935-1944
260. Monticelli LA, Sonnenberg GF, Abt MC, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011 ; 12: 1045-1054
261. Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol. 2012 ; 30: 647-675
262. Crowe CR, Chen K, Pociask DA, et al. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol. 2009 ; 183: 5301-5310
263. McKinstry KK, Strutt TM, Buck A, et al. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol. 2009 ; 182: 7353-7363
264. Hale BG, Randall RE, Ortin J, et al. The multifunctional NS1 protein of influenza A viruses. J Gen Virol. 2008 ; 89: 2359-2376
265. Donelan NR, Basler CF, Garcia-Sastre A. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol. 2003 ; 77: 13257-13266
266. Ayllon J, Hale BG, Garcia-Sastre A. Strain-specific contribution of NS1-activated phosphoinositide 3-kinase signaling to influenza A virus replication and virulence. J Virol. 2012 ; 86: 5366-5370
267. Ma W, Brenner D, Wang Z, et al. The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J Virol. 2010 ; 84: 2122-2133
268. Billharz R, Zeng H, Proll SC, et al. The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J Virol. 2009 ; 83: 10557-10570
269. Marazzi I, Ho JS, Kim J, et al. Suppression of the antiviral response by an influenza histone mimic. Nature. 2012 ; 483: 428-433
270. Gack MU, Albrecht RA, Urano T, et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009 ; 5: 439-449
271. Lin L, Li Y, Pyo HM, et al. Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle. J Virol. 2012 ; 86: 1942-1954
272. Stasakova J, Ferko B, Kittel C, et al. Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol. 2005 ; 86: 185-195
273. Conenello GM, Zamarin D, Perrone LA, et al. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 2007 ; 3: 1414-1421
274. Mitzner D, Dudek SE, Studtrucker N, et al. Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol. 2009 ; 11: 1502-1516
275. Le Goffic R, Leymarie O, Chevalier C, et al. Transcriptomic analysis of host immune and cell death responses associated with the influenza A virus PB1-F2 protein. PLoS Pathog. 2011 ; 7: e1002202 - e1002202
276. Smith AM, Adler FR, McAuley JL, et al. Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics. PLoS Comput Biol. 2011 ; 7: e1001081 - e1001081
277. Mazur I, Anhlan D, Mitzner D, et al. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol. 2008 ; 10: 1140-1152
278. McAuley JL, Hornung F, Boyd KL, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe. 2007 ; 2: 240-249
279. Jagger BW, Wise HM, Kash JC, et al. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science. 2012 ; 337: 199-204
280. Shi M, Jagger BW, Wise HM, et al. Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A virus. J Virol. 2012 ; 86: 12411-12413
281. Yewdell JW, Ince WL. Virology. Frameshifting to PA-X influenza. Science. 2012 ; 337: 164-165
282. Shapira SD, Gat-Viks I, Shum BO, et al. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell. 2009 ; 139: 1255-1267
283. Tuvim MJ, Evans SE, Clement CG, et al. Augmented lung inflammation protects against influenza A pneumonia. PLoS ONE. 2009 ; 4: e4176 - e4176
284. Tuvim MJ, Gilbert BE, Dickey BF, et al. Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia. PLoS One. 2012 ; 7: e30596 - e30596
285. Zhao J, Wohlford-Lenane C, Fleming E, et al. Intranasal treatment with poly(I∗C) protects aged mice from lethal respiratory virus infections. J Virol. 2012 ; 86: 11416-11424
286. Ayala VI, Teijaro JR, Farber DL, et al. Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity. PLoS One. 2011 ; 6: e19016 - e19016
287. Crouch E, Nikolaidis N, McCormack FX, et al. Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo. J Biol Chem. 2011 ; 286: 40681-40692
288. Hartshorn KL, White MR, Rynkiewicz M, et al. Monoclonal antibody-assisted structure-function analysis of the carbohydrate recognition domain of surfactant protein D. Am J Physiol Lung Cell Mol Physiol. 2010 ; 299: L384 - L392
289. Crouch E, Hartshorn K, Horlacher T, et al. Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343. Biochemistry. 2009 ; 48: 3335-3345
290. Hartshorn KL, White MR, Smith K, et al. Increasing antiviral activity of surfactant protein d trimers by introducing residues from bovine serum collectins: dissociation of mannan-binding and antiviral activity. Scand J Immunol. 2009 ; 72: 22-30
291. White MR, Boland P, Tecle T, et al. Enhancement of antiviral activity of collectin trimers through cross-linking and mutagenesis of the carbohydrate recognition domain. J Innate Immun. 2010 ; 2: 267-792
292. Tecle T, White MR, Sorensen G, et al. Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus. Biochem J. 2008 ; 412: 323-329
293. van Eijk M, Rynkiewicz MJ, White MR, et al. A unique sugar-binding site mediates the distinct anti-influenza activity of pig surfactant protein D. J Biol Chem. 2012 ; 287: 26666-26677
294. van Eijk M, Bruinsma L, Hartshorn KL, et al. Introduction of N-linked glycans in the lectin domain of surfactant protein D: impact on interactions with influenza A viruses. J Biol Chem. 2011 ; 286: 20137-20151
295. White MR, Crouch E, Chang D, et al. Enhanced antiviral and opsonic activity of a human mannose-binding lectin and surfactant protein D chimera. J Immunol. 2000 ; 165: 2108-2115
296. Daly NL, Chen YK, Rosengren KJ, et al. Retrocyclin-2: a potent anti-HIV theta-defensin that forms a cyclic cystine ladder structural motif. Adv Exp Med Biol. 2009 ; 611: 577-578
297. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science. 2012 ; 335: 936-941
298. Vlahos R, Stambas J, Bozinovski S, et al. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog. 2011 ; 7: e1001271 - e1001271
299. Marcelin G, Aldridge JR, Duan S, et al. Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice. J Virol. 2011 ; 85: 11208-11219
300. Carey MA, Bradbury JA, Rebolloso YD, et al. Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice. PLoS One. 2010 ; 5: e11610 - e11610
301. Aldridge JR, Moseley CE, Boltz DA, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A. 2009 ; 106: 5306-1153
302. Cloutier A, Marois I, Cloutier D, et al. The prostanoid 15-deoxy-Delta12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection. J Infect Dis. 2010 ; 205: 621-630
303. Budd A, Alleva L, Alsharifi M, et al. Increased survival after gemfibrozil treatment of severe mouse influenza. Antimicrob Agents Chemother. 2007 ; 51: 2965-2968
304. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008 ; 198: 962-970
305. Stegemann S, Dahlberg S, Kroger A, et al. Increased susceptibility for superinfection with Streptococcus pneumoniae during influenza virus infection is not caused by TLR7-mediated lymphopenia. PLoS One. 2009 ; 4: e4840 - e4840
306. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics. 2008 ; 122: 805-811
307. Lee LN, Dias P, Han D, et al. A mouse model of lethal synergism between influenza virus and Haemophilus influenzae. Am J Pathol. 2010 ; 176: 800-811
308. Kudva A, Scheller EV, Robinson KM, et al. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol. 2011 ; 186: 1666-1674
309. Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest. 2009 ; 119: 1910-1920
310. Li W, Moltedo B, Moran TM. Type I Interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of gammadelta T cells. J Virol. 2012 ; 86: 12304-12312
311. Juno J, Fowke KR, Keynan Y. Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses. Clin Dev Immunol. 2012 ; 2012: 797180-797180
312. Antonopoulou A, Baziaka F, Tsaganos T, et al. Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection. Int J Infect Dis. 2012 ; 16: e204-208
313. Ferdinands JM, Denison AM, Dowling NF, et al. A pilot study of host genetic variants associated with influenza-associated deaths among children and young adults. Emerg Infect Dis. 2012 ; 17: 2294-2302
314. Hidaka F, Matsuo S, Muta T, et al. A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin Immunol. 2006 ; 119: 188-194
315. Esposito S, Molteni CG, Giliani S, et al. Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children. Virol J. 2012 ; 9: 270-270
316. Zhang H, Zhou G, Zhi L, et al. Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis. 2005 ; 192: 1355-1361
317. LahtI M, Lofgren J, Martilla T, et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res. 2002 ; 51: 696-699
318. Wang P, Bai F, Zenewicz LA, et al. IL-22 signaling contributes to West Nile encephalitis pathogenesis. PLoS One. 2011 ; 7: e44153 - e44153
319. Huber S, Gagliani N, Zenewicz LA, et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature. 2012 ; 491: 259-263